ITP
Iron Triangle Partners Portfolio holdings
AUM
$632M
This Quarter Return
+4.09%
1 Year Return
+26.53%
3 Year Return
+134.07%
5 Year Return
+312.1%
10 Year Return
–
AUM
$954M
AUM Growth
+$954M
(-1.3%)
Cap. Flow
+$4.61M
Cap. Flow
% of AUM
0.48%
Top 10 Holdings %
Top 10 Hldgs %
58.71%
Holding
37
New
9
Increased
10
Reduced
5
Closed
13
Top Buys
| 1 |
Edwards Lifesciences
EW
|
$67.2M |
| 2 |
Insulet
PODD
|
$53.3M |
| 3 |
Danaher
DHR
|
$46.7M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$45.7M |
| 5 |
Inspire Medical Systems
INSP
|
$37.7M |
Top Sells
| 1 |
Icon
ICLR
|
$50.7M |
| 2 |
Exact Sciences
EXAS
|
$48.3M |
| 3 |
Align Technology
ALGN
|
$46.6M |
| 4 |
Illumina
ILMN
|
$45.4M |
| 5 |
Bruker
BRKR
|
$43.8M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Edwards Lifesciences
EW
$47.8B
| $67.2M | 6.83% | +727,180 | New | +$67.2M |
|
2
DexCom
DXCM
$29.5B
| $66M | 6.71% | 582,199 +110,568 | +23% | +$12.5M |
|
3
Glaukos
GKOS
$5.5B
| $60.1M | 6.11% | 508,156 +78,631 | +18% | +$9.31M |
|
4
Acadia Healthcare
ACHC
$2.12B
| $56.7M | 5.76% | 839,075 -63,738 | -7% | -$4.3M |
|
5
Intuitive Surgical
ISRG
$170B
| $53.8M | 5.47% | 120,986 -3,351 | -3% | -$1.49M |
|
6
McKesson
MCK
$85.4B
| $53.8M | 5.47% | 92,125 +54,706 | +146% | +$32M |
|
7
Teva Pharmaceuticals
TEVA
$21.1B
| $53.6M | 5.45% | 3,300,185 +530,321 | +19% | +$8.62M |
|
|
8
Insulet
PODD
$23.9B
| $53.3M | 5.42% | +264,041 | New | +$53.3M |
|
9
AbbVie
ABBV
$372B
| $48.8M | 4.96% | 284,657 +8,559 | +3% | +$1.47M |
|
|
10
Danaher
DHR
$147B
| $46.7M | 4.75% | +187,011 | New | +$46.7M |
|
11
Elanco Animal Health
ELAN
$9.12B
| $46.6M | 4.74% | 3,228,439 +1,931,307 | +149% | +$27.9M |
|
|
12
BioMarin Pharmaceuticals
BMRN
$11.2B
| $45.7M | 4.65% | +555,140 | New | +$45.7M |
|
13
West Pharmaceutical
WST
$17.8B
| $43.8M | 4.45% | 132,908 +13,172 | +11% | +$4.34M |
|
14
Brookdale Senior Living
BKD
$1.83B
| $39.6M | 4.03% | 5,801,941 -96,019 | -2% | -$656K |
|
|
15
Inspire Medical Systems
INSP
$2.77B
| $37.7M | 3.84% | +281,992 | New | +$37.7M |
|
16
Oscar Health
OSCR
$4.31B
| $29M | 2.95% | 1,832,256 +497,753 | +37% | +$7.87M |
|
17
Insmed
INSM
$28.8B
| $27.7M | 2.81% | +413,196 | New | +$27.7M |
|
18
Neurocrine Biosciences
NBIX
$13.8B
| $27.5M | 2.8% | 200,000 -20,000 | -9% | -$2.75M |
|
19
argenx
ARGX
$43.6B
| $26.5M | 2.7% | 61,704 +16,704 | +37% | +$7.18M |
|
20
Twist Bioscience
TWST
$1.63B
| $25.9M | 2.64% | +526,455 | New | +$25.9M |
|
21
Schrodinger
SDGR
$1.44B
| $21.9M | 2.23% | 1,133,102 +269,779 | +31% | +$5.22M |
|
22
Agilon Health
AGL
$530M
| $16.5M | 1.68% | +2,519,416 | New | +$16.5M |
|
23
908 Devices
MASS
$226M
| $3.75M | 0.38% | 728,865 -311,903 | -30% | -$1.61M |
|
|
ALMS
24
Alumis Inc. Common Stock
ALMS
$479M
| $1.66M | 0.17% | +125,000 | New | +$1.66M |
|
25
Cytokinetics
CYTK
$4.23B
| – | – | -300,000 | Closed | -$21M |
|